Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Tangible Net Worth Ratio
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Tangible Net Worth Ratio of 75.5% as of March 2026. This metric is calculated by deducting intangible assets (CN¥432.71 Million) from net assets (CN¥1.77 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Guangdong Taienkang Pharmaceutical Co. L equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Guangdong Taienkang Pharmaceutical Co. Ltd Tangible Net Worth Ratio (2019–2025)
This chart shows how Guangdong Taienkang Pharmaceutical Co. Ltd's Tangible Net Worth Ratio has changed across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 75.5%, reflecting net assets of CN¥1.77 Billion with intangible assets of CN¥432.71 Million CNY. For live market cap and overall valuation, see Guangdong Taienkang Pharmaceutical Co. L (301263) total market value.
Annual Tangible Net Worth Ratio for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2025, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 301263 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 75.2% | CN¥1.74 Billion | CN¥431.41 Million | CN¥2.42 Billion | ▼ -6.4 pp |
| 2024 | 81.7% | CN¥1.82 Billion | CN¥332.97 Million | CN¥2.31 Billion | ▼ -3.2 pp |
| 2023 | 84.9% | CN¥1.83 Billion | CN¥276.46 Million | CN¥2.23 Billion | ▼ -10.2 pp |
| 2022 | 95.1% | CN¥1.85 Billion | CN¥91.74 Million | CN¥2.04 Billion | ▲ +4.1 pp |
| 2021 | 90.9% | CN¥709.81 Million | CN¥64.44 Million | CN¥941.52 Million | ▲ +0.7 pp |
| 2020 | 90.2% | CN¥589.63 Million | CN¥57.75 Million | CN¥834.75 Million | ▲ +1.1 pp |
| 2019 | 89.1% | CN¥498.40 Million | CN¥54.33 Million | CN¥679.56 Million | — |